Product Information
Registration Status: ActiveSIN15822P
AFSTYLA POWDER AND SOLVENT FOR SOLUTION FOR INJECTION 500IU/VIAL is approved to be sold in Singapore with effective from 2019-09-27. It is marketed by CSL BEHRING PTE LTD, with the registration number of SIN15822P.
This product contains Lonoctocog Alfa 500IU/vial in the form of INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION. It is approved for INTRAVENOUS use.
This product is manufactured by CSL Behring GmbH (Powder and Solvent) in GERMANY.
It is a Prescription Only Medicine that can only be obtained from a doctor or a dentist, or a pharmacist with a prescription from a Singapore-registered doctor or dentist.
Product Reference
Important Note: For generic product, the SPC/PIL provided may not be brand specific.
{{/items}} {{^items}}Indication
For the treatment of hemophilia A, von Willebrand disease and Factor XIII deficiency.
Mechanism of Action
Antihemophilic factor (AHF) is a protein found in normal plasma which is necessary for clot formation. The administration of AHF provides an increase in plasma levels of AHF and can temporarily correct the coagulation defect of patients with hemophilia A (classical hemophilia).
Clearance
* 4.1 mL/h•kg [Previously treated pediatric patients]
Active Ingredient/Synonyms
Lonoctocog alfa | Lonoctocog alfa |
Source of information: Drugbank (External Link). Last updated on: 3rd July 18. *Trade Name used in the content below may not be the same as the HSA-registered product.